Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:56:26.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no substantive changes to the study page content.
    Difference
    0.0%
    Check dated 2026-03-18T17:51:02.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:19:28.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Minor admin changes: a new page revision label (v3.4.2) appears, and an outdated government funding notice banner is removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:23:04.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government funding status notice regarding the NIH Clinical Center's operations and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-03T23:01:44.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC status wording to 'Last Update Submitted that Met QC Criteria', and added 'No FEAR Act Data' with the revision noted as 'Revision: v3.4.0'. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T20:52:10.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.